Tech Company Financing Transactions

Gliknik Funding Round

Gliknik closed a Series B venture capital round on 5/14/2013. Investors included private investors.

Transaction Overview

Company Name
Announced On
5/14/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
801 West Baltimore St. 501A
Baltimore, MD 21201
USA
Email Address
Not Recorded
Overview
Gliknik develops therapies for patients with cancer and immune disorders.
Profile
Gliknik LinkedIn Company Profile
Social Media
Gliknik Company Twitter Account
Company News
Gliknik News
Facebook
Gliknik on Facebook
YouTube
Gliknik on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Block
  David Block LinkedIn Profile  David Block Twitter Account  David Block News  David Block on Facebook
Vice President
Henrik Olsen
  Henrik Olsen LinkedIn Profile  Henrik Olsen Twitter Account  Henrik Olsen News  Henrik Olsen on Facebook
VP - Bus. Development
Jeffrey Herpst
  Jeffrey Herpst LinkedIn Profile  Jeffrey Herpst Twitter Account  Jeffrey Herpst News  Jeffrey Herpst on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/14/2013: Postmaster venture capital transaction
Next: 5/14/2013: Plated venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary